This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Lipton, A. Articles by King, L. Search for Related Content PubMed PubMed Citation Articles by Lipton, A. Articles by King, L.

Advances in Treating Metastatic Bone Cancer: Summary Statement for the First Cambridge Conference

Authors' Affiliations: ¹ Milton S. Hershey Medical Center, Penn State University College of Medicine, Hershey, Pennsylvania; ² Institute for Myeloma and Bone Cancer Research, West Hollywood, California; ³ Department of Internal Medicine, Institut Jules Bordet and CHU Brugmann, Université Libre de Bruxelles, Bruxelles, Belgium; ⁴ Department of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York; ⁵ Department of Oncology, Norwegian Radium Hospital, Oslo, Norway; ⁶ The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland; ⁷ Department of Symptom Research, The University of Texas M.D. Anderson Cancer Center, Houston, Texas; ⁸ Department of Orthopedic Surgery, University of Minnesota Cancer Center, Minneapolis, Minnesota; ⁹ Academic Unit of Clinical Oncology, Cancer Research Centre, Weston Park Hospital, Sheffield, United Kingdom; ¹⁰ Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, Ontario, Canada; ¹¹ Department of Endocrinology and Medicine, University of Virginia, Charlottesville, Vancouver; ¹² Department of Medicine, Division of Hematology/Oncology, Cornell University Medical College, New York, New York; ¹³ Parkside Oncology Centre, London, United Kingdom; ¹⁴ Bone Research Group, Institute of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom; ¹⁵ University of Pittsburgh, Pittsburgh, Pennsylvania; ¹⁶ Massachusetts General Hospital Cancer Center, Division of Hematology-Oncology, Harvard Medical School, Boston, Massachusetts; ¹⁷ Center for Orthopaedic Research, University of Arkansas for Medical Sciences, Little Rock, Arizona; ¹⁸ Genitourinary Cancer Research Laboratory, University of Washington School of Medicine, Seattle, Washington; ¹⁹ Division of Oncology, Washington University School of Medicine, St. Louis, Missouri; and ²⁰ InforMEDical Communications, Inc., Carlisle, Massachusetts

Requests for reprints: Allan Lipton, Milton S. Hershey Medical Center, Penn State University College of Medicine, 500 University Drive, H046, P.O. Box 850, Hershey, PA 17033-0850. Phone: 717-531-5960; E-mail: alipton{at}psu.edu.

The First Cambridge Conference on Advances in Treating Metastatic Bone Cancer, a symposium held in Cambridge, Massachusetts, October 28 to 29, 2005, was convened to discuss recent advances and research related to the natural history of bone metastases and skeletal complications, bone cancer biology, treatment of myeloma and other solid tumors, and treatment-induced bone loss. The conference format combined brief presentations with extended periods of discussion. The conclusions reached during the 2-day meeting are summarized in this article and presented in more detail in the individual articles and accompanying discussion sessions that comprise the conference proceedings.